These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 7829403)
1. Photodynamic therapy using a diode laser with mono-L-aspartyl chlorin e6 for implanted fibrosarcoma in mice. Katsumi T; Aizawa K; Okunaka T; Kuroiwa Y; Ii Y; Saito K; Konaka C; Kato H Jpn J Cancer Res; 1994 Nov; 85(11):1165-70. PubMed ID: 7829403 [TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy with a diode laser for implanted fibrosarcoma in mice employing mono-L-aspartyl chlorin E6. Katsumi TA; Aizawa K; Kuroiwa Y; Saito K; Kurata Y; Ii Y; Okunaka T; Konaka C; Kato H Photochem Photobiol; 1996 Oct; 64(4):671-5. PubMed ID: 8863472 [TBL] [Abstract][Full Text] [Related]
3. Photodynamic effect using a diode laser with mono-l-aspartyl chlorin e6 (NPe6) for implanted mouse tumor. Katsumi T; Kato H; Okunaka T; Kuroiwa Y; Yoshiteru I; Saito K; Konaka C; Aizawa K J Clin Laser Med Surg; 1994 Aug; 12(4):211-3. PubMed ID: 10147480 [TBL] [Abstract][Full Text] [Related]
4. Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessels and its contribution to the antitumor effect. Saito K; Mikuniya N; Aizawa K Jpn J Cancer Res; 2000 May; 91(5):560-5. PubMed ID: 10835502 [TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: experimental study on an animal model of nude mouse. Kobayashi W; Liu Q; Nakagawa H; Sakaki H; Teh B; Matsumiya T; Yoshida H; Imaizumi T; Satoh K; Kimura H Oral Oncol; 2006 Jan; 42(1):46-50. PubMed ID: 16266818 [TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy of intestinal tumors with mono-L-aspartyl chlorin e6 (NPe6): a basic study. Kikuchi T; Asakura T; Aihara H; Shiraki M; Takagi S; Kinouchi Y; Aizawa K; Shimosegawa T Anticancer Res; 2003; 23(6C):4897-900. PubMed ID: 14981942 [TBL] [Abstract][Full Text] [Related]
7. Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung. Kato H; Furukawa K; Sato M; Okunaka T; Kusunoki Y; Kawahara M; Fukuoka M; Miyazawa T; Yana T; Matsui K; Shiraishi T; Horinouchi H Lung Cancer; 2003 Oct; 42(1):103-11. PubMed ID: 14512194 [TBL] [Abstract][Full Text] [Related]
8. Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries. Nagae T; Aizawa K; Uchimura N; Tani D; Abe M; Fujishima K; Wilson SE; Ishimaru S Lasers Surg Med; 2001; 28(4):381-8. PubMed ID: 11344521 [TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study. Taber SW; Fingar VH; Coots CT; Wieman TJ Clin Cancer Res; 1998 Nov; 4(11):2741-6. PubMed ID: 9829737 [TBL] [Abstract][Full Text] [Related]
10. [Potential of photodynamic therapy with a second-generation sensitizer: mono-L-aspartyl chlorin e6]. Mori K; Ohta M; Sano A; Yoneya S; Sonoda M; Kaneda A; Sato Y Nippon Ganka Gakkai Zasshi; 1997 Feb; 101(2):134-40. PubMed ID: 9124093 [TBL] [Abstract][Full Text] [Related]
11. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model. Wong Kee Song LM; Wang KK; Zinsmeister AR Cancer; 1998 Jan; 82(2):421-7. PubMed ID: 9445202 [TBL] [Abstract][Full Text] [Related]
12. Pilot study of topical delivery of mono-L-aspartyl chlorin e6 (NPe6): implication of topical NPe6-photodynamic therapy. Wong TW; Aizawa K; Sheyhedin I; Wushur C; Kato H J Pharmacol Sci; 2003 Oct; 93(2):136-42. PubMed ID: 14578580 [TBL] [Abstract][Full Text] [Related]
13. Morphologic evaluation of the antitumor activity of photodynamic therapy (PDT) using mono-L-aspartyl chlorin e6 (NPe6) against uterine cervical carcinoma cell lines. Nakamura H; Suzuki Y; Takeichi M; Saito T; Takayama M; Aizawa K Int J Gynecol Cancer; 2002; 12(2):177-86. PubMed ID: 11975677 [TBL] [Abstract][Full Text] [Related]
14. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model. Ferrario A; Kessel D; Gomer CJ Cancer Res; 1992 May; 52(10):2890-3. PubMed ID: 1581904 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces. Chan AL; Juarez M; Allen R; Volz W; Albertson T Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):72-8. PubMed ID: 15752124 [TBL] [Abstract][Full Text] [Related]
16. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model. Gomer CJ; Ferrario A Cancer Res; 1990 Jul; 50(13):3985-90. PubMed ID: 2354446 [TBL] [Abstract][Full Text] [Related]
17. Retreatment effect of NPe6 photodynamic therapy on the normal primate macula. Nakashizuka T; Mori K; Hayashi N; Anzail K; Kanail K; Yoneya S; Moshfeghi DM; Peyman GA Retina; 2001; 21(5):493-8. PubMed ID: 11642379 [TBL] [Abstract][Full Text] [Related]
18. Killing tumor cells: the effect of photodynamic therapy using mono-L-aspartyl chlorine and NS-398. Harvey EH; Webber J; Kessel D; Fromm D Am J Surg; 2005 Mar; 189(3):302-5. PubMed ID: 15792755 [TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy using mono-L-aspartyl chlorin e6 for rabbit experimental hepatoma. Nakamura J; Kajiwara H J Hepatobiliary Pancreat Surg; 1999; 6(3):312-9. PubMed ID: 10526068 [TBL] [Abstract][Full Text] [Related]
20. Localization of experimental submucosal esophageal tumor in rabbits by using mono-L-aspartyl chlorin e6 and long-wavelength photodynamic excitation. Sheyhedin I; Okunaka T; Kato H; Yamamoto Y; Sakaniwa N; Konaka C; Aizawa K Lasers Surg Med; 2000; 26(1):83-9. PubMed ID: 10637007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]